Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 8 of 23
Northsea Therapeutics
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2017
Hold
9yr
Owners
2
Nuevocor
Angelini Ventures
FranceSector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Owners
2
Numaferm
HTGF III
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Owners
2
Numi
Heartcore Capital Fund IV
FranceSector
Biotech
InvestorHeartcore Capital
Entry
2023
Hold
3yr
Owners
2
OxThera
Sunstone Life Science Ventures IV
SE
Sector
Biotech
InvestorSunstone Life Science Ventures
Entry
2016
Hold
10yr
Owners
2
Page Therapeutics
XGEN Venture Life Sciences Fund
SwitzerlandSector
Biotech
InvestorXGen Venture SGR
Entry
2024
Hold
2yr
Owners
2
Palobiofarma
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2010
Hold
16yr
Owners
2
Pencil Biosciences
Northern Gritstone Evergreen
UKSector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
Owners
2
Peptomyc
Alta Life Sciences Spain I FCR
SpainSector
Biotech
InvestorAlta Life Sciences
Entry
2016
Hold
10yr
Owners
2
Pharvaris
Kurma Biofund III
FranceSector
Biotech
InvestorEurazeo
Entry
2019
Hold
7yr
Owners
2
Quell Therapeutics
SV7 Impact Medicine Fund
United KingdomSector
Biotech
InvestorSV Health Managers
Entry
2021
Hold
5yr
Owners
2
Ray Therapeutics
Novo Holdings Venture Investments
USSector
Biotech
InvestorNovo Holdings
Entry
2021
Hold
5yr
Owners
2
Refoxy Pharma
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2024
Hold
2yr
Owners
2
Refoxy Pharmaceuticals
Boehringer Ingelheim Venture Fund
GermanySector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
Owners
2
Resalis Therapeutics
Sunstone Life Science Ventures V
ItalySector
Biotech
InvestorSunstone Life Science Ventures
Entry
2021
Hold
5yr
Owners
2
Rhizocore Technologies
Nucleus Capital I
United KingdomSector
Biotech
InvestorNucleus Capital
Entry
2022
Hold
4yr
Owners
2
Rondo Therapeutics
Novo Holdings Venture Investments
United StatesSector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
Owners
2
Scenic Biotech
Eir Ventures I
NetherlandsSector
Biotech
InvestorEir Ventures
Entry
2017
Hold
9yr
Owners
2
Scripta
YZR Capital Fund I
United KingdomSector
Biotech
InvestorYZR Capital
Entry
2025
Hold
1yr
Owners
2
SNIPR Biome
Wellington Partners Life Sciences
DenmarkSector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Owners
2
Stalicla
LIFTT
FranceSector
Biotech
InvestorLIFTT
Entry
2021
Hold
5yr
Owners
2
Synendos Therapeutics
Ysios BioFund III
FranceSector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
6yr
Owners
2
Tenpoint Therapeutics
AFB Fund II
FranceSector
Biotech
InvestorAdBio Partners
Entry
2022
Hold
4yr
Owners
2
TES Pharma
Indaco BIO
ItalySector
Biotech
InvestorIndaco Venture Partners SGR
Entry
2024
Hold
2yr
Owners
2
Thermosome
Seedfonds Bayern
GermanySector
Biotech
InvestorBayern Kapital
Entry
2015
Hold
11yr
Owners
2
TRIMTECH Therapeutics
CIC Fund II
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2023
Hold
3yr
Owners
2
Umlaut.bio
HTGF IV
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2024
Hold
2yr
Owners
2
Vytrus Biotech
Zamit Capital
SpainSector
Biotech
InvestorGVC Gaesco Alternative Investments
Entry
2019
Hold
7yr
Owners
2
Whitelab Genomics
Omnes Real Tech 1
FranceSector
Biotech
InvestorOmnes Capital
Entry
2020
Hold
6yr
Owners
2
Xenothera
MH Innov'
FranceSector
Biotech
InvestorMalakoff Humanis Innov'
Entry
2021
Hold
5yr
Owners
2
2invest AG (formerly 4basebio AG)
Deutsche Balaton Evergreen Holding (Balance Sheet)
GermanySector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2020
Hold
6yr
300K Solutions
ADE Capital Sodical
SpainSector
Biotech
InvestorSodical
Entry
2024
Hold
2yr
3P Biovian
Sodena Direct
SpainSector
Biotech
InvestorSodena
Entry
2007
Hold
19yr
4basebio PLC
Deutsche Balaton Evergreen Holding (Balance Sheet)
United KingdomSector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2021
Hold
5yr
4TEEN4 Pharmaceuticals
NRW.Venture
GermanySector
Biotech
InvestorNRW.BANK
Entry
2019
Hold
7yr
65Lab
Leaps by Bayer
Singapore
Sector
Biotech
InvestorLeaps by Bayer
Entry
2023
Hold
3yr
AAVantgarde
XGEN Venture Life Sciences Fund
ItalySector
Biotech
InvestorXGen Venture SGR
Entry
2025
Hold
1yr
Accipiter Biosciences
Columbus Life Sciences Fund IV
United StatesSector
Biotech
InvestorColumbus Venture Partners
Entry
2025
Hold
1yr
AcousticaBio
Vento Fund I
United StatesSector
Biotech
InvestorVento
Entry
2023
Hold
3yr
Adaptam Therapeutics
Criteria Bio Ventures
SpainSector
Biotech
InvestorCaixa Capital Risc
Entry
2025
Hold
1yr
Addition Therapeutics
Abingworth Bioventures IX
USSector
Biotech
InvestorAbingworth
Entry
2025
Hold
1yr
Adicet Bio
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2021
Hold
5yr
Aelis Farma
ACI (Aquitaine Creation Investissement)
FranceSector
Biotech
InvestorAquiti Gestion
Entry
2016
Hold
10yr
AELIX Therapeutics
Ysios BioFund II Innvierte
ES
Sector
Biotech
InvestorYsios Capital Partners
Entry
2016
Hold
10yr
Aeovian Pharmaceuticals
Apollo Health Ventures Fund I
United StatesSector
Biotech
InvestorApollo Health Ventures
Entry
2019
Hold
7yr
AFFiRiS
MIG Fonds 5
AustriaSector
Biotech
InvestorMIG Capital
Entry
2006
Hold
20yr
Affirma Bio
Nara Health Capital
SpainSector
Biotech
InvestorNara Capital Partners
Entry
2024
Hold
2yr
Aglaris
CRB Bio II
United KingdomSector
Biotech
InvestorCRB Health Tech
Entry
2016
Hold
10yr
AiCuris
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2006
Hold
20yr
Akero Therapeutics
General Atlantic Growth Equity Fund
USASector
Biotech
InvestorGeneral Atlantic
Entry
–